Review
Fast Facts
Contact Info and Support
Traffic information
| Category | Metrics | Meaning |
|---|---|---|
| Ratings | Global Rank | - |
| Country Code | - | |
| Country Rank | - | |
| Category Rank | - | |
| Engagement metrics | Visits | 0 |
| Bounce Rate | 0 | |
| Pageviews per Visit | 0 | |
| Avg. Visit Duration | 0 | |
| Estimated monthly visits | July 2025 | 0 |
| August 2025 | 0 | |
| September 2025 | 0 | |
| Traffic sources | Social | - |
| Paid Referrals | - | |
| - | ||
| Referrals | - | |
| Search | - | |
| Direct | - |
About HeynepMarkets
HeynepMarkets operates via the domain heynepmarkets.com. According to the UK’s Financial Conduct Authority (FCA), this entity—listed as “HNM (UK) Limited / heynepmarkets.com”—is a clone firm. It falsely uses details of a legitimate FCA-authorized company, HYCM Capital Markets (UK) Limited, FRN 186171, with no actual connection to the cloned firm. The clone firm is not authorized to provide financial services, and consumers engaging with it do not receive Financial Ombudsman Service access or Financial Services Compensation Scheme protection. The warning was issued on 15 August 2022.
Multiple independent reviews confirm that HeynepMarkets lacks any valid regulation from recognized authorities. The broker has no registration with the UK FCA, CySEC, ASIC, CIMA, or DFSA, and the license numbers it cites belong to other firms such as HYCM. It is considered unregulated and unsafe. Some reviews cite a minimum deposit of $100 and leverage up to 1:500, but these claims are unsubstantiated by any regulatory documentation.
Who it’s for
- There is no verified information supporting a legitimate target audience due to the absence of official licensing or reliable documentation.
Pros and cons
Pros
- No credible advantages can be confirmed, as regulatory and operational information cannot be substantiated.
Cons
- Clone firm impersonating an FCA-authorized broker, HYCM Capital Markets (UK) Limited .
- No valid regulation from any recognized supervisory body (FCA, CySEC, ASIC, CIMA, DFSA) , .
- High-risk leverage claims (e.g., up to 1:500) lack regulatory support .













